Skip to content
Home/Companies/Biotech/Synklino

Synklino

Biotech·Denmark·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Synklino?

Synklino is currently owned by Eifo through EIFO (direct equity) (1992 vintage), since 2020.

Hand-verified · updated 2026-08-18

Eifo
Investor
Eifo
EIFO (direct equity) · 1992 · VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from EIFO (direct equity)

Other portfolio companies in the same fund.

Adcendo
Adcendo
Active
BiotechDenmark· 2026
Bactolife
Active
BiotechDenmark· 2026
Serpier
Active
AdTechDenmark· 2026
Six Robotics
Active
Aerospace & DefenceDenmark· 2026
Streamwerk
Active
SoftwareDenmark· 2026
Lotus Microsystems
Active
Deep TechDenmark· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Synklino

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Synklino?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Synklino.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue